Junge Zhang

Junge Zhang discloses dealings in Ocugen, Inc. to SEC (Form 4). The record holds 32 filings, for trades running from 30 September 2019 to 1 April 2026.

In open-market terms, that means 23 purchases worth €486k on one side and 2 sales worth €4.3M on the other. Sales outweigh purchases by €3.8M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 2 share grants and 5 option exercises.

A typical purchase (the median) is worth €6,826. Of 23 purchases, 21 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

Most recently, on 2 April 2026, the filings show an option exercise worth €6,600 in Ocugen, Inc. The last insider purchase was made public on 16 June 2023, 1,226 days ago. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.